staurosporine has been researched along with Protein Aggregation, Pathological in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, P; Liu, ZP; Shi, XL; Wu, JD | 1 |
| Dickson, DW; Gan, M; Jiang, P; McLean, PJ; Moussaud, S; Yen, SH | 1 |
| Davies, P; Eversden, S; Gibson, Y; Goodson, R; Hamilton, L; Hutton, M; Jones, S; Kestoras, D; Mead, E; O'Neill, M; Szekeres, P; Wolak, J | 1 |
3 other study(ies) available for staurosporine and Protein Aggregation, Pathological
| Article | Year |
|---|---|
Synthesis and evaluation of novel GSK-3β inhibitors as multifunctional agents against Alzheimer's disease.
Topics: Alzheimer Disease; Amides; Amines; Animals; Antioxidants; Blood-Brain Barrier; Cell Line; Chelating Agents; Drug Design; Glycogen Synthase Kinase 3 beta; Humans; PC12 Cells; Protein Aggregation, Pathological; Protein Kinase Inhibitors; Rats; Structure-Activity Relationship; tau Proteins | 2019 |
Proaggregant nuclear factor(s) trigger rapid formation of α-synuclein aggregates in apoptotic neurons.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Apoptosis; Brain; Cell Line, Tumor; Cytosol; Disease Models, Animal; Humans; Lamin Type B; Mice, Inbred C57BL; Neurons; Nuclear Envelope; Oxidopamine; Phosphorylation; Protein Aggregation, Pathological; Staurosporine | 2016 |
Halting of Caspase Activity Protects Tau from MC1-Conformational Change and Aggregation.
Topics: Animals; Caspase Inhibitors; Caspases; Cell Line, Tumor; Copper-Transporting ATPases; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Humans; Mice; Protein Aggregation, Pathological; Protein Conformation; Staurosporine; tau Proteins | 2016 |